Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient’s native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. Since their introduction in patients in 1991, aortic stent graft devices have gained wide acceptance and availability, with their adoption fueled in great part by advances in stent-graft design and by a variety of devices for various anatomic features. Over time, these devices have gained traction for use in patients with ruptured aneurysms because they are minimally invasive and have shorter recovery times.

The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

• Investigation of current and future market competition for Aortic Stent Grafts.
• Competitor assessment including device approval analysis.
• Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
• Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
• Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice.

Reasons to buy

• Gain a high level view of the trends shaping and driving the Aortic Stent Grafts market.
• Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
• Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
• Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
• Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 10

3 Competitive Assessment 11
3.1 Overview 11
3.2 Key Marketed Products 11
3.2.1 Endovascular Aneurysm Repair and Thoracic Endovascular Aneurysm Repair Products 11

4 Pipeline Assessment 22
4.1 Overview 22
4.2 Product Profiles 22
4.2.1 Altura Medical Endograft 22
4.2.2 Cordis INCRAFT 23
4.2.3 EndoSpan Horizon 24
4.2.4 EndoSpan Nexus 25
4.2.5 MicroPort Scientific Castor Branched Stent Graft System 26
4.2.6 BiFlow Medical Novel Side-Branch Stent 27
4.2.7 Endoluminal Sciences Endograft Mechanism 28
4.2.8 Medtronic Valiant Mona LSA Stent Graft System 29
4.2.9 Endologix Ventana Fenestrated Stent Graft 29

5 Current and Future Players 31
5.1 Overview 31
5.2 Trends in Corporate Strategy 31
5.3 Company Profiles 32
5.3.1 Cook Medical 32
5.3.2 Endologix 35
5.3.3 Gore Medical 38
5.3.4 Medtronic 40
5.3.5 Terumo Corporation 43
5.3.6 Altura Medical 45
5.3.7 Aptus Endosystems 46
5.3.8 Bolton Medical 48
5.3.9 Braile Biomédica 50
5.3.10 B. Braun 53
5.3.11 Cardiatis 54
5.3.12 LeMaitre Vascular 56
5.3.13 Lifetech Scientific 58
5.3.14 Getinge Group 60
5.3.15 Grikin Advanced Materials 63
5.3.16 Johnson & Johnson’s Cordis Corporation 64
5.3.17 Jotec 66
5.3.18 Lombard Medical 68
5.3.19 MicroPort Scientific Corporation 69
5.3.20 Nano Endoluminal 72
5.3.21 TriVascular 74
5.3.22 Weike Medical Apparatus and Instrument 77
5.3.23 YTH Biological Material Scitech 77

6 Appendix 78
6.1 Bibliography 78
6.2 Abbreviations 92
6.3 Research Methodology 95
6.3.1 Overview 95
6.3.2 Coverage 95
6.3.3 Secondary Research 95
6.4 Physicians and Specialists Included in this Study 97
6.4.1 Christopher Abularrage, MD, FACS 97
6.4.2 Gaspar Mestres Alomar, MD 97
6.4.3 Enio Buffolo, MD, PhD 97
6.4.4 Ludovic Canaud, MD, PhD 97
6.4.5 Holger Eggebrecht, MD 97
6.4.6 Daisuke Fukui, MD, PhD 97
6.4.7 Germano Melissano, MD 97
6.4.8 Dr. Raghuram Sekhar MS, FRCS (Edinburgh), FRCS (Glasgow) 97
6.4.9 Ferdinand Serracino-Inglott, MD, MSc, FRCSI, FRCS (Gen Surg), DIC 98
6.4.10 Jiang Xiong, MD, PhD 98
6.5 Primary Research 99
6.5.1 Primary Research - Key Opinion Leader Interviews 99
6.5.2 Primary Research - Physician and Industry Interviews 99
6.5.3 Expert Panel Validation 100
6.6 Forecasting Methodology 101
6.7 About the Authors 102
6.7.1 Analysts 102
6.7.2 Global Head of Healthcare 103
6.8 About MediPoint 104
6.9 About GlobalData 104
6.10 Disclaimer 104

List of Tables

Table 1: Zenith Family Marketed Products 13
Table 2: Zenith AAA SWOT 13
Table 3: Zenith TAA SWOT 14
Table 4: Endologix’s Marketed Products 15
Table 5: AFX Endovascular SWOT 15
Table 6: IntuiTrak Powerlink System SWOT 15
Table 7: Gore Medical’s Marketed Products 17
Table 8: Gore AAA Product SWOT 17
Table 9: Gore TAA Product SWOT 18
Table 10: Medtronic’s Marketed Products 19
Table 11: Medtronic AAA Product SWOT 20
Table 12: Medtronic TAA Product SWOT 20
Table 13: Terumo Corporation Marketed Products 21
Table 14: Terumo Corporation AAA Product SWOT 21
Table 15: SWOT Analysis - Altura Medical Endograft 23
Table 16: SWOT Analysis - Cordis INCRAFT 24
Table 17: SWOT Analysis - EndoSpan Horizon 25
Table 18: SWOT Analysis - EndoSpan Nexus 26
Table 19: SWOT Analysis - MicroPort Scientific Castor Branched Stent Graft System 27
Table 20: SWOT Analysis - BiFlow Medical Novel Side-Branch Stent 28
Table 21: SWOT Analysis - Endoluminal Sciences Endograft Mechanism 28
Table 22: SWOT Analysis - Medtronic Valiant Mona LSA Stent Graft 29
Table 23: SWOT Analysis - Endologix Ventana Fenestrated Stent Graft 30
Table 24: Company Profile - Cook Medical 33
Table 25: Cook Medical Marketed Products 34
Table 26: SWOT Analysis - Cook Medical 35
Table 27: Company Profile - Endologix Inc. 36
Table 28: Endologix Marketed Products 37
Table 29: Endologix Pipeline Products 37
Table 30: SWOT Analysis - Endologix Inc. 37
Table 31: Company Profile - Gore Medical 38
Table 32: Gore Medical Marketed Products 39
Table 33: SWOT Analysis - Gore Medical 40
Table 34: Company Profile - Medtronic 41
Table 35: Medtronic Marketed Products 42
Table 36: SWOT Analysis - Medtronic 42
Table 37: Company Profile - Terumo Corporation 43
Table 38:Terumo Corporation Marketed Products 44
Table 39: SWOT Analysis - Terumo Corporation 45
Table 40: Company Profile - Altura Medical Inc. 45
Table 41: Altura Medical Inc. Marketed Products 46
Table 42: SWOT Analysis - Altura Medical Inc. 46
Table 43: Company Profile - Aptus Endosystems, Inc. 47
Table 44: Aptus Endosystems Inc. Marketed Products 48
Table 45: SWOT Analysis - Aptus Endosystems Inc. 48
Table 46: Company Profile - Bolton Medical 49
Table 47: Bolton Medical Marketed Products 50
Table 48: SWOT Analysis - Bolton Medical 50
Table 49: Company Profile - Braile Biomédica 51
Table 50: Braile Biomédica Marketed Products 52
Table 51: SWOT Analysis - Braile Biomédica 52
Table 52: Company Profile - B. Braun 53
Table 53: B. Braun Marketed Products 54
Table 54: SWOT Analysis - B. Braun 54
Table 55: Company Profile - Cardiatis 55
Table 56: Cardiatis Marketed Products 55
Table 57: SWOT Analysis - Cardiatis 56
Table 58: Company Profile - LeMaitre Vascular 57
Table 59: LeMaitre Vascular Medical Marketed Products 57
Table 60: SWOT Analysis - LeMaitre Vascular 58
Table 61: Company Profile - Lifetech Scientific 59
Table 62: Lifetech Scientific Marketed Products 59
Table 63: SWOT Analysis - Lifetech Scientific 60
Table 64: Company Profile - Getinge Group 61
Table 65: Getinge Group Marketed Products 62
Table 66: SWOT Analysis - Getinge Group 62
Table 67: Company Profile - Grikin Advanced Materials 63
Table 68: Grikin Advanced Materials Marketed Products 63
Table 69: SWOT Analysis - Grikin Advanced Materials 64
Table 70: Company Profile - Johnson & Johnson Cordis Corporation 64
Table 71: Cordis Corporation’s Pipeline Product 65
Table 72: SWOT Analysis - Cordis Corporation 65
Table 73: Company Profile - Jotec 66
Table 74: Jotec’s Marketed Products 67
Table 75: SWOT Analysis - Jotec 67
Table 76: Company Profile - Lombard Medical 68
Table 77: Lombard Medical Marketed Products 69
Table 78: SWOT Analysis - Lombard Medical 69
Table 79: Company Profile - Microport Scientific Corporation 70
Table 80: MicroPort Scientific Marketed Products 71
Table 81: SWOT Analysis - MicroPort Scientific 72
Table 82: Company Profile - Nano Endoluminal 73
Table 83: Nano Endoluminal Medical Marketed Products 73
Table 84: SWOT Analysis - Nano Endoluminal 74
Table 85: Company Profile - TriVascular 75
Table 86: TriVascular Marketed Products 76
Table 87: SWOT Analysis - TriVascular 76

List of Figures

Figure 1: Aortic Stent Graft Primary Research, Supply and Demand-Side Interviews 100